These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28499535)

  • 1. Cancer Recognition and Screening for Common Breast Disorders and Malignancy.
    Bohon C
    Obstet Gynecol Clin North Am; 2017 Jun; 44(2):257-270. PubMed ID: 28499535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk-adapted surveillance: focus on familial breast and ovarian cancer].
    Rhiem K; Schmutzler RK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):307-11. PubMed ID: 24562705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer.
    Wu H; Zhu K; Jatoi I; Shah M; Shriver CD; Potter J
    Breast Cancer Res Treat; 2007 Mar; 101(3):317-24. PubMed ID: 16821080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of early diagnostic tools for breast cancer].
    Shen SJ; Sun Q; Xu YL; Zhou YD; Guan JH; Mao F; Lin Y; Wang XJ; Han SM
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):877-80. PubMed ID: 23291142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.
    Hughes KS; Roche C; Campbell CT; Siegel N; Salisbury L; Chekos A; Katz MS; Edell E
    Breast J; 2003; 9(1):19-25. PubMed ID: 12558666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
    Brannon Traxler L; Martin ML; Kerber AS; Bellcross CA; Crane BE; Green V; Matthews R; Paris NM; Gabram SG
    Ann Surg Oncol; 2014 Oct; 21(10):3342-7. PubMed ID: 25047474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
    Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry.
    Campitelli MA; Chiarelli AM; Mirea L; Stewart L; Glendon G; Ritvo P; Andrulis IL; Knight JA
    Eur J Cancer Prev; 2011 Nov; 20(6):492-500. PubMed ID: 21691207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.
    Halapy EE; Chiarelli AM; Klar N; Knight J
    J Med Screen; 2004; 11(1):32-8. PubMed ID: 15006112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast care--an overview.
    White E
    Nurs Times; 2000 Oct 5-11; 96(40):35-6. PubMed ID: 11968641
    [No Abstract]   [Full Text] [Related]  

  • 13. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
    Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
    Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.
    Warner E; Plewes DB; Shumak RS; Catzavelos GC; Di Prospero LS; Yaffe MJ; Goel V; Ramsay E; Chart PL; Cole DE; Taylor GA; Cutrara M; Samuels TH; Murphy JP; Murphy JM; Narod SA
    J Clin Oncol; 2001 Aug; 19(15):3524-31. PubMed ID: 11481359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial breast and ovarian cancer: a Swedish population-based register study.
    Anderson H; Bladström A; Olsson H; Möller TR
    Am J Epidemiol; 2000 Dec; 152(12):1154-63. PubMed ID: 11130621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and evaluation of a palpable breast mass.
    Pruthi S
    Mayo Clin Proc; 2001 Jun; 76(6):641-7; quiz 647-8. PubMed ID: 11393504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of education based on the health belief model on screening behavior in high risk women for breast cancer, Tehran, Iran.
    Hajian S; Vakilian K; Najabadi KM; Hosseini J; Mirzaei HR
    Asian Pac J Cancer Prev; 2011; 12(1):49-54. PubMed ID: 21517230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-negative MRI breast screening in high-risk women.
    Maxwell AJ; Lim YY; Hurley E; Evans DG; Howell A; Gadde S
    Clin Radiol; 2017 Mar; 72(3):207-216. PubMed ID: 27932250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.
    Gronwald J; Huzarski T; Byrski B; Medrek K; Menkiszak J; Monteiro AN; Sun P; Lubinski J; Narod SA
    J Med Genet; 2006 May; 43(5):424-8. PubMed ID: 16227521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing.
    Foulkes WD; Narod SA
    Clin Invest Med; 1995 Dec; 18(6):473-83. PubMed ID: 8714791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.